Pallando Therapeutics

Private

San Carlos, CaliforniaHealthcare & Life Scienceshttps://pallandotx.com/

Last Round

Seed

Jun 24, 2025

Total Funding Raised

$8M

Company Overview

Pallando Therapeutics is a biotechnology company that provides precision targeting services intended to transform the oncology treatment landscape.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

biotechnologyoncology therapeuticsprecision medicinedrug discoverytargeted protein degradationnext-gen degradersai-augmented drug discoverystealth biotechtherapeutic pipelineprecision targetingbiotech startupr&d partnershipspharma licensingcomputational biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pallando Therapeutics Comparables

Compare Pallando Therapeutics with similar companies based on industry and business-model similarity.

Pallando Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
TenSixty Bio	81%
Bayer AG	73%
TRIANA Biomedicines	71%

View all Comparables

Pallando Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jun 24, 2025

View all Funding Rounds

Pallando Therapeutics Investors

Notable investors and investment history

Pallando Therapeutics investors
Investor	Rounds
General Catalyst	Seed
BVF Partners L.P.	Seed
Astellas Venture Management	Seed
8VC	Seed

View all Investors

Pallando Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Pallando Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pallando Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Carlos, California

Employee Range7

Year Founded2023

Last FundingJun 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?